Drug Type Small molecule drug |
Synonyms YFJ 36 |
Target |
Action modulators |
Mechanism β-lactamase modulators(Beta Lactamase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acinetobacter Baumannii Infection | Preclinical | China | 10 Apr 2024 | |
| Klebsiella pneumoniae infection | Preclinical | China | 10 Apr 2024 |





